The new weapons in the war against COVID-19
Global virus treatments are evolving beyond vaccines as countries discover there are more ways than one to deal with the pandemic.
Social distancing at a traffic junction on Orchard Road, Singapore. Getty
Singapore/Jakarta | Vaccines are not the only option when it comes to fighting COVID-19. In Singapore on Thursday, the country’s Health Sciences Authority expedited the approval for GlaxoSmithKline’s new therapy.
GSK’s sotrovimab is designed to stop mild or moderate COVID-19 from progressing to severe disease. In the US, regulators brought a trial of the new drug, developed by GSK with Vir Biotechnology, to an early close because the results were so good. There was an 85 per cent reduction in hospitalisation or death in those receiving sotrovimab compared with those taking a placebo.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Asia
Fetching latest articles